(Q24337486)

extrinsic apoptotic signaling pathway

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

8

Naoki Yamamoto

0 references

Thomas S. Wilkinson

0 references

author name string

Rachel M McLoughlin

1

0 references

Suzanne M Hurst

2

0 references

Mari A Nowell

3

0 references

Dean A Harris

4

0 references

Sankichi Horiuchi

5

0 references

Llinos W Morgan

6

0 references

Thomas S Wilkinson

7

0 references

Nicholas Topley

9

0 references

Simon A Jones

Chemotactic agents induce IL-6Ralpha shedding from polymorphonuclear cells: involvement of a metalloproteinase of the TNF-alpha-converting enzyme (TACE) type

10

0 references

language of work or name

English

0 references

publication date

1 May 2004

0 references

published in

Journal of Immunology

0 references

volume

172

0 references

issue

9

0 references

page(s)

5676-83

0 references

cites work

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

The soluble interleukin-6 receptor is generated by shedding

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

Interferon-alpha and interferon-gamma down-regulate the production of interleukin-8 and ENA-78 in human monocytes

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptor.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

Chemokines: a new classification system and their role in immunity

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

IL-6 and Its Soluble Receptor Orchestrate a Temporal Switch in the Pattern of Leukocyte Recruitment Seen during Acute Inflammation

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

Blood monocytes consist of two principal subsets with distinct migratory properties

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

Chemokines and leukocyte traffic

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

Impaired immune and acute-phase responses in interleukin-6-deficient mice.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

High-level production of alternatively spliced soluble interleukin-6 receptor in serum of patients with adult T-cell leukaemia/HTLV-I-associated myelopathy

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

The CXC Chemokines Growth-regulated Oncogene (GRO) α, GROβ, GROγ, Neutrophil-activating Peptide-2, and Epithelial Cell-derived Neutrophil-activating Peptide-78 Are Potent Agonists for the Type B, but Not the Type A, Human Interleukin-8 Receptor

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

Interleukin-8 (IL-8), melanoma growth-stimulatory activity, and neutrophil-activating peptide selectively mediate priming of the neutrophil NADPH oxidase through the type A or type B IL-8 receptor

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

Chemokine antagonists that discriminate between interleukin-8 receptors. Selective blockers of CXCR2.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

STAT3 acts as a co-activator of glucocorticoid receptor signaling

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

Chemokine-cytokine cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

Soluble cytokine receptors are present in normal human urine

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

C-reactive protein: a physiological activator of interleukin 6 receptor shedding.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

The soluble interleukin 6 receptor: mechanisms of production and implications in disease

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

Purification and characterization of the soluble interleukin-6 receptor from human plasma and identification of an isoform generated through alternative splicing

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

The detection of a novel neutrophil-activating peptide (ENA-78) using a sensitive ELISA

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

CCR3 Expression Induced by IL-2 and IL-4 Functioning as a Death Receptor for B Cells

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021

Soluble IL-6 Receptor Governs IL-6 Activity in Experimental Arthritis: Blockade of Arthritis Severity by Soluble Glycoprotein 130

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.172.9.5676

7 January 2021